Absher Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,476
| Closed | -$526K | – | 52 |
|
|
2022
Q1 | $526K | Sell |
9,476
-2,962
| -24% | -$164K | 0.09% | 47 |
|
|
2021
Q4 | $697K | Sell |
12,438
-1,048
| -8% | -$58.7K | 0.12% | 45 |
|
|
2021
Q3 | $647K | Sell |
13,486
-2,266
| -14% | -$109K | 0.12% | 45 |
|
|
2021
Q2 | $660K | Buy |
15,752
+720
| +5% | +$30.2K | 0.12% | 45 |
|
|
2021
Q1 | $507K | Buy |
15,032
+2,004
| +15% | +$67.6K | 0.1% | 50 |
|
|
2020
Q4 | $455K | Buy |
13,028
+724
| +6% | +$25.3K | 0.1% | 48 |
|
|
2020
Q3 | $427K | Buy |
12,304
+70
| +0.6% | +$2.43K | 0.1% | 48 |
|
|
2020
Q2 | $401K | Sell |
12,234
-4,852
| -28% | -$159K | 0.1% | 51 |
|
|
2020
Q1 | $514K | Buy |
17,086
+136
| +0.8% | +$4.09K | 0.16% | 42 |
|
|
2019
Q4 | $511K | Buy |
+16,950
| New | +$511K | 0.13% | 42 |
|